Cargando…
Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden
BACKGROUND: Redox stress is a hallmark of the rewired metabolic phenotype of cancer. The underlying dysregulation of reactive oxygen species (ROS) is interconnected with abnormal mitochondrial biogenesis and function. In chronic lymphocytic leukemia (CLL), elevated ROS are implicated in clonal outgr...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453051/ https://www.ncbi.nlm.nih.gov/pubmed/26041471 http://dx.doi.org/10.1186/s12943-015-0378-1 |
_version_ | 1782374406154092544 |
---|---|
author | Prinz, Christian Vasyutina, Elena Lohmann, Gregor Schrader, Alexandra Romanski, Steffen Hirschhäuser, Christoph Mayer, Petra Frias, Corazon Herling, Carmen D. Hallek, Michael Schmalz, Hans-Günther Prokop, Aram Mougiakakos, Dimitrios Herling, Marco |
author_facet | Prinz, Christian Vasyutina, Elena Lohmann, Gregor Schrader, Alexandra Romanski, Steffen Hirschhäuser, Christoph Mayer, Petra Frias, Corazon Herling, Carmen D. Hallek, Michael Schmalz, Hans-Günther Prokop, Aram Mougiakakos, Dimitrios Herling, Marco |
author_sort | Prinz, Christian |
collection | PubMed |
description | BACKGROUND: Redox stress is a hallmark of the rewired metabolic phenotype of cancer. The underlying dysregulation of reactive oxygen species (ROS) is interconnected with abnormal mitochondrial biogenesis and function. In chronic lymphocytic leukemia (CLL), elevated ROS are implicated in clonal outgrowth and drug resistance. The pro-survival oncogene T-cell leukemia 1 (TCL1) is causally linked to the high threshold towards classical apoptosis in CLL. We investigated how aberrant redox characteristics and bioenergetics of CLL are impacted by TCL1 and if this is therapeutically exploitable. METHODS: Bio-organometallic chemistry provided compounds containing a cytosine nucleobase, a metal core (ferrocene, ruthenocene, Fe(CO)(3)), and a 5’-CH2O-TDS substituent. Four of these metal-containing nucleoside analogues (MCNA) were tested for their efficacy and mode of action in CLL patient samples, gene-targeted cell lines, and murine TCL1-transgenic splenocytes. RESULTS: The MCNA showed a marked and selective cytotoxicity towards CLL cells. MCNA activity was equally observed in high-risk disease groups, including those of del11q/del17p cytogenetics and of clinical fludarabine resistance. They overcame protective stromal cell interactions. MCNA-evoked PARP-mediated cell death was non-autophagic and non-necrotic as well as caspase- and P53-independent. This unconventional apoptosis involved early increases of ROS, which proved indispensible based on mitigation of MCNA-triggered death by various scavengers. MCNA exposure reduced mitochondrial respiration (oxygen consumption rate; OCR) and induced a rapid membrane depolarization (∆ΨM). These characteristics distinguished the MCNA from the alkylator bendamustine and from fludarabine. Higher cellular ROS and increased MCNA sensitivity were linked to TCL1 expression. The presence of TCL1 promoted a mitochondrial release of in part caspase-independent apoptotic factors (AIF, Smac, Cytochrome-c) in response to MCNA. Although basal mitochondrial respiration (OCR) and maximal respiratory capacity were not affected by TCL1 overexpression, it mediated a reduced aerobic glycolysis (lactate production) and a higher fraction of oxygen consumption coupled to ATP-synthesis. CONCLUSIONS: Redox-active substances such as organometallic nucleosides can confer specific cytotoxicity to ROS-stressed cancer cells. Their P53- and caspase-independent induction of non-classical apoptosis implicates that redox-based strategies can overcome resistance to conventional apoptotic triggers. The high TCL1-oncogenic burden of aggressive CLL cells instructs their particular dependence on mitochondrial energetic flux and renders them more susceptible towards agents interfering in mitochondrial homeostasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0378-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4453051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44530512015-06-04 Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden Prinz, Christian Vasyutina, Elena Lohmann, Gregor Schrader, Alexandra Romanski, Steffen Hirschhäuser, Christoph Mayer, Petra Frias, Corazon Herling, Carmen D. Hallek, Michael Schmalz, Hans-Günther Prokop, Aram Mougiakakos, Dimitrios Herling, Marco Mol Cancer Research BACKGROUND: Redox stress is a hallmark of the rewired metabolic phenotype of cancer. The underlying dysregulation of reactive oxygen species (ROS) is interconnected with abnormal mitochondrial biogenesis and function. In chronic lymphocytic leukemia (CLL), elevated ROS are implicated in clonal outgrowth and drug resistance. The pro-survival oncogene T-cell leukemia 1 (TCL1) is causally linked to the high threshold towards classical apoptosis in CLL. We investigated how aberrant redox characteristics and bioenergetics of CLL are impacted by TCL1 and if this is therapeutically exploitable. METHODS: Bio-organometallic chemistry provided compounds containing a cytosine nucleobase, a metal core (ferrocene, ruthenocene, Fe(CO)(3)), and a 5’-CH2O-TDS substituent. Four of these metal-containing nucleoside analogues (MCNA) were tested for their efficacy and mode of action in CLL patient samples, gene-targeted cell lines, and murine TCL1-transgenic splenocytes. RESULTS: The MCNA showed a marked and selective cytotoxicity towards CLL cells. MCNA activity was equally observed in high-risk disease groups, including those of del11q/del17p cytogenetics and of clinical fludarabine resistance. They overcame protective stromal cell interactions. MCNA-evoked PARP-mediated cell death was non-autophagic and non-necrotic as well as caspase- and P53-independent. This unconventional apoptosis involved early increases of ROS, which proved indispensible based on mitigation of MCNA-triggered death by various scavengers. MCNA exposure reduced mitochondrial respiration (oxygen consumption rate; OCR) and induced a rapid membrane depolarization (∆ΨM). These characteristics distinguished the MCNA from the alkylator bendamustine and from fludarabine. Higher cellular ROS and increased MCNA sensitivity were linked to TCL1 expression. The presence of TCL1 promoted a mitochondrial release of in part caspase-independent apoptotic factors (AIF, Smac, Cytochrome-c) in response to MCNA. Although basal mitochondrial respiration (OCR) and maximal respiratory capacity were not affected by TCL1 overexpression, it mediated a reduced aerobic glycolysis (lactate production) and a higher fraction of oxygen consumption coupled to ATP-synthesis. CONCLUSIONS: Redox-active substances such as organometallic nucleosides can confer specific cytotoxicity to ROS-stressed cancer cells. Their P53- and caspase-independent induction of non-classical apoptosis implicates that redox-based strategies can overcome resistance to conventional apoptotic triggers. The high TCL1-oncogenic burden of aggressive CLL cells instructs their particular dependence on mitochondrial energetic flux and renders them more susceptible towards agents interfering in mitochondrial homeostasis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0378-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-04 /pmc/articles/PMC4453051/ /pubmed/26041471 http://dx.doi.org/10.1186/s12943-015-0378-1 Text en © Prinz et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Prinz, Christian Vasyutina, Elena Lohmann, Gregor Schrader, Alexandra Romanski, Steffen Hirschhäuser, Christoph Mayer, Petra Frias, Corazon Herling, Carmen D. Hallek, Michael Schmalz, Hans-Günther Prokop, Aram Mougiakakos, Dimitrios Herling, Marco Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title | Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title_full | Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title_fullStr | Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title_full_unstemmed | Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title_short | Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden |
title_sort | organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ros dependent and facilitated by tcl1-oncogene burden |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453051/ https://www.ncbi.nlm.nih.gov/pubmed/26041471 http://dx.doi.org/10.1186/s12943-015-0378-1 |
work_keys_str_mv | AT prinzchristian organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT vasyutinaelena organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT lohmanngregor organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT schraderalexandra organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT romanskisteffen organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT hirschhauserchristoph organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT mayerpetra organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT friascorazon organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT herlingcarmend organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT hallekmichael organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT schmalzhansgunther organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT prokoparam organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT mougiakakosdimitrios organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden AT herlingmarco organometallicnucleosidesinducenonclassicalleukemiccelldeaththatismitochondrialrosdependentandfacilitatedbytcl1oncogeneburden |